Cellistic
Mont-Saint-Guibert, Belgium
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Cellistic
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Mont-Saint-Guibert, Belgium
- Modalities
- iPSC, iPSC-derived Cell Therapy, CAR-NK, Allogeneic Cell Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Cellistic
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesiPSC, iPSC-derived Cell Therapy, CAR-NK, Allogeneic Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (4 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (4 modalities)
Recent News 10 articles
Ncardia Launches Cellistic™, the Only iPSC-based Cell Therapy Process Development & Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BioInformant
Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction - Business Wire
Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to advance Immuno-Oncology and Regenerative Cell Therapies - BioInformant
Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies - PharmaTimes
The Future of Allogeneic Cell Therapy is Off-the-Shelf and iPSC-Based – An Interview with Cellistic’s Founder and CTO, Stefan Braam, PhD - BioInformant
Cellistic Launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell Lines facilitating cost-effective cell therapy development - BioInformant
BrightPath and Cellistic partner for trials of CAR-T cell therapy - Clinical Trials Arena
Cellistic adds CRISPR tech through Artisan Bio asset buy - BioProcess International
Cellistic® Announces Successful Certification of its GMP Facility Dedicated to iPSC-Based Off-the-shelf Cell Therapy Manufacturing Solutions - BioInformant
Press Release Service: BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell - CRISPR Medicine News
Frequently Asked Questions About Cellistic
What is Cellistic's CDMO Signal Score?
Cellistic has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Cellistic for a manufacturing program?
Use the free AI matchmaker to compare Cellistic against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
FUJIFILM Cellular Dynamics (FCDI)
Madison, WI
iPSC, iPSC-derived Cell Therapy, cGMP iPSC Banking, iPSC Differentiation
RoslinCT
Edinburgh, UK · Hopkinton, MA
Signal Score: 80.2
CAR-T, Cell Therapy, iPSC, Gene Editing
Cellipont Bioservices
The Woodlands, TX
Cell Therapy, CAR-T, MSC, iPSC, Exosome, Autologous, Allogeneic
Porton Advanced
Cranbury, NJ
Lentiviral Vector, AAV, Adenoviral Vector, Plasmid DNA, CAR-T, TCR-T, CAR-NK, HSC, Exosome, mRNA
Magellan Stem Cells
Sydney, Australia
Cell Therapy, MSC, CAR-T, NK Cell, iPSC, Exosome, Fibroblast